Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Research Article
  • Published:

Decreased vascular reactivity associated with increased IL-8 in 6-month-old infants of mothers with pre-eclampsia

Abstract

Background

Offspring born to mothers with pre-eclampsia (Pre-E) suffer higher risks of adult cardiovascular diseases, suggesting that exposure to an antiangiogenic environment in-utero has a lasting impact on the development of endothelial function. The goal of this study is to test the hypothesis that in-utero exposure to Pre-E results in alterations of angiogenic factors/cytokines that negatively impact vascular development during infancy.

Methods

Infants born from mothers with and without Pre-E were recruited and followed up at 6 months. Plasma cytokines, blood pressure, microvessel density, and vascular reactivity were assessed.

Results

6-month-old infants born to mothers with Pre-E had unchanged blood pressure (p = 0.86) and microvessel density (p = 0.57). Vascular reactivity was decreased in infants born to mothers with Pre-E compared to infants born to healthy mothers (p = 0.0345). Interleukin 8 (IL-8) (p = 0.03) and Angiopoeitin-2 (Ang-2) (p = 0.04) were increased in infants born to mothers with Pre-E. We observed that higher IL-8 was associated with lower vascular reactivity (rho = −0.14, p < 0.0001).

Conclusion

At 6 months of age, infants born to mothers with Pre-E had impaired vascular reactivity and higher IL-8 and Ang-2, but similar blood pressure and microvessel density compared to infants born to non-Pre-E mothers.

Impact Statement

  • Changes in cord blood antiangiogenic factors are documented in infants of mothers with pre-eclampsia and may contribute to offspring risks of adult cardiovascular disease. How these factors evolve during early infancy and their correlation with offspring vascular development have not been studied.

  • This study found that 6-month-old infants born to mothers with pre-eclampsia had decreased vascular reactivity, which was correlated with higher IL-8.

  • These findings underscore the lasting impact of maternal pre-eclampsia on offspring vascular development and highlight the need for long-term follow-up in children born to mothers with pre-eclampsia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Study cohorts and assessed outcomes.
Fig. 2: Plasma cytokine levels of infants at 6 months follow up.
Fig. 3: Spearman Correlation demonstrating association between different cytokines.

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Boakye, E. et al. Nativity-related disparities in preeclampsia and cardiovascular disease risk among a racially diverse cohort of US Women. JAMA Netw. Open 4, e2139564 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Irgens, H. U., Reisæter, L., Irgens, L. M. & Lie, R. T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323, 1213–1217 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Yang, L. et al. Maternal hypertensive disorders during pregnancy and the risk of offspring diabetes mellitus in childhood, adolescence, and early adulthood: a nationwide population-based cohort study. BMC Med. 21, 59 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hecht, J. L. et al. The pathology of eclampsia: An autopsy series. Hypertens. Pregnancy 36, 259–268 (2017).

    Article  CAS  PubMed  Google Scholar 

  5. Weel, I. C. et al. Association between placental lesions, cytokines and angiogenic factors in pregnant women with Preeclampsia. PLoS ONE 11, e0157584 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Clark, D. E. et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol. Reprod. 59, 1540–1548 (1998).

    Article  CAS  PubMed  Google Scholar 

  7. Tangerås, L. H. et al. Distinct first trimester cytokine profiles for gestational hypertension and preeclampsia. Arterioscler. Thromb. Vasc. Biol. 35, 2478–2485 (2015).

    Article  PubMed  Google Scholar 

  8. Tomimatsu, T. et al. Preeclampsia: Maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. Int. J. Mol. Sci. 20, 4246 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Heath-Freudenthal, A. et al. Vascular disorders of pregnancy increase susceptibility to neonatal pulmonary hypertension in high-altitude populations. Hypertens. Dallas Tex. 1979 79, 1286–1296 (2022).

    CAS  Google Scholar 

  10. Vinayagam, V., Bobby, Z., Habeebullah, S., Chaturvedula, L. & Bharadwaj, S. K. Maternal and cord blood plasma sEng and TGF-β1 in patients with hypertensive disorders of pregnancy: a pilot study in a South. Indian Popul. J. Clin. Diagn. Res. JCDR 11, QC32–QC34 (2017).

    CAS  Google Scholar 

  11. Kim, D.-H., Shin, S. H., Kim, E.-K. & Kim, H.-S. Association of increased cord blood soluble endoglin with the development of bronchopulmonary dysplasia in preterm infants with maternal preeclampsia. Pregnancy Hypertens. 13, 148–153 (2018).

    Article  PubMed  Google Scholar 

  12. Sezer, S. D. et al. Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early- and late-onset pre-eclampsia. Gynecol. Endocrinol. J. Int. Soc. Gynecol. Endocrinol. 28, 628–632 (2012).

    Article  CAS  Google Scholar 

  13. Antonios, T. F. T. et al. Capillary remodeling in infants born to hypertensive pregnancy: pilot study. Am. J. Hypertens. 25, 848–853 (2012).

    Article  PubMed  Google Scholar 

  14. Varley, B. J. et al. Intrauterine exposure to preeclampsia does not impair vascular health in children. Front. Public Health 10, 1071304 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Nahum Sacks, K. et al. Prenatal exposure to preeclampsia as an independent risk factor for long-term cardiovascular morbidity of the offspring. Pregnancy Hypertens. 13, 181–186 (2018).

    Article  PubMed  Google Scholar 

  16. Ren, C. L. et al. Forced expiratory flows and diffusion capacity in infants born from mothers with pre-eclampsia. Pediatr. Pulmonol. 57, 2481–2490 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kramer, M. S. et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 108, E35 (2001).

    Article  CAS  PubMed  Google Scholar 

  18. Acosta, J. C. et al. Gestational diabetes mellitus alters maternal and neonatal circulating endothelial progenitor cell subsets. Am. J. Obstet. Gynecol. 204, 254.e8–254.e15 (2011).

    Article  PubMed  Google Scholar 

  19. DiMeglio, L. A. et al. Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae? J. Pediatr. 157, 540–546 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Martin, H., Gazelius, B. & Norman, M. Impaired acetylcholine-induced vascular relaxation in low birth weight infants: implications for adult hypertension? Pediatr. Res. 47, 457–462 (2000).

    Article  CAS  PubMed  Google Scholar 

  21. Krispinsky, L. T. et al. Endothelial-dependent vasomotor dysfunction in infants after cardiopulmonary bypass. Pediatr. Crit. Care Med. J. Soc. Crit. Care Med. World Fed. Pediatr. Intensive Crit. Care Soc. 21, 42–49 (2020).

    Google Scholar 

  22. Hubble, S. M. A., Kyte, H. L., Gooding, K. & Shore, A. C. Variability in sublingual microvessel density and flow measurements in healthy volunteers. Microcirculation 16, 183–191 (2009).

    Article  PubMed  Google Scholar 

  23. Bezemer, R. et al. Rapid automatic assessment of microvascular density in sidestream dark field images. Med. Biol. Eng. Comput. 49, 1269–1278 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hypertension in Pregnancy: Executive Summary. Obstet. Gynecol. 122, 1122 (2013).

  25. Källén, B., Finnström, O., Nygren, K.-G. & Olausson, P. O. Association between preterm birth and intrauterine growth retardation and child asthma. Eur. Respir. J. 41, 671–676 (2013).

    Article  PubMed  Google Scholar 

  26. Nakimuli, A. et al. Relative impact of pre-eclampsia on birth weight in a low resource setting: A prospective cohort study. Pregnancy Hypertens. 21, 1–6 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  27. Xiong, X., Demianczuk, N. N., Saunders, L. D., Wang, F.-L. & Fraser, W. D. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am. J. Epidemiol. 155, 203–209 (2002).

    Article  PubMed  Google Scholar 

  28. Liu, Y. et al. Impact of gestational hypertension and preeclampsia on low birthweight and small-for-gestational-age infants in China: A large prospective cohort study. J. Clin. Hypertens. 23, 835–842 (2021).

    Article  CAS  Google Scholar 

  29. Yang, Y. et al. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw. Open 4, e218401 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  30. Weil, B. R., Stauffer, B. L., Greiner, J. J. & DeSouza, C. A. Prehypertension is associated with impaired nitric oxide-mediated endothelium-dependent vasodilation in sedentary adults. Am. J. Hypertens. 24, 976–981 (2011).

    Article  PubMed  Google Scholar 

  31. Stockelman, K. A. et al. Negative influence of insufficient sleep on endothelial vasodilator and fibrinolytic function in hypertensive adults. Hypertension 78, 1829–1840 (2021).

    Article  CAS  PubMed  Google Scholar 

  32. Cemgil Arikan, D., Aral, M., Coskun, A. & Ozer, A. Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. J. Matern. -Fetal Neonatal Med. J. Eur. Assoc. Perinat. Med. Fed. Asia Ocean. Perinat. Soc. Int. Soc. Perinat. Obstet. 25, 1569–1573 (2012).

    CAS  Google Scholar 

  33. Han, S. Y., Jun, J. K., Lee, C.-H., Park, J. S. & Syn, H. C. Angiopoietin-2: a promising indicator for the occurrence of severe preeclampsia. Hypertens. Pregnancy 31, 189–199 (2012).

    Article  CAS  PubMed  Google Scholar 

  34. Yue, T. L. et al. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ. Res. 75, 1–7 (1994).

    Article  CAS  PubMed  Google Scholar 

  35. Li, A., Dubey, S., Varney, M. L., Dave, B. J. & Singh, R. K. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated Angiogenesis1. J. Immunol. 170, 3369–3376 (2003).

    Article  CAS  PubMed  Google Scholar 

  36. Boekholdt, S. M. et al. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler. Thromb. Vasc. Biol. 24, 1503–1508 (2004).

    Article  CAS  PubMed  Google Scholar 

  37. Szarka, A., Rigó, J., Lázár, L., Bekő, G. & Molvarec, A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 11, 1–9 (2010).

    Article  Google Scholar 

  38. Ambalavanan, N. et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 123, 1132–1141 (2009).

    Article  PubMed  Google Scholar 

  39. Akwii, R. G., Sajib, M. S., Zahra, F. T. & Mikelis, C. M. Role of Angiopoietin-2 in vascular physiology and pathophysiology. Cells 8, 471 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Patel, J. V., Lim, H. S., Varughese, G. I., Hughes, E. A. & Lip, G. Y. H. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension. Ann. Med. 40, 215–222 (2008).

    Article  CAS  PubMed  Google Scholar 

  41. Medvedeva, T. A. & Kushnarenko, N. N. Angiopoietin-2 is a new predictor of arterial stiffness and diastolic heart failure in gouty patients with arterial hypertension. Atherosclerosis 331, e229 (2021).

    Article  Google Scholar 

  42. Aghai, Z. H. et al. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone. J. Perinatol. J. Calif. Perinat. Assoc. 28, 149–155 (2008).

    CAS  Google Scholar 

  43. Dionne, J. M., Abitbol, C. L. & Flynn, J. T. Hypertension in infancy: diagnosis, management and outcome. Pediatr. Nephrol. Berl. Ger. 27, 17–32 (2012).

    Article  Google Scholar 

  44. Flynn, J. T. et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140, e20171904 (2017).

    Article  PubMed  Google Scholar 

  45. van den Berg, V. J. et al. Reproducibility of microvascular vessel density analysis in Sidestream dark-field-derived images of healthy term newborns. Microcirc. N. Y. N. 1994 22, 37–43 (2015).

    Google Scholar 

  46. van Elteren, H. A., Ince, C., Tibboel, D., Reiss, I. K. M. & de Jonge, R. C. J. Cutaneous microcirculation in preterm neonates: comparison between sidestream dark field (SDF) and incident dark field (IDF) imaging. J. Clin. Monit. Comput. 29, 543–548 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the Multiplex Analysis Core at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center for providing support in analyzing samples and interpretation of data.

Funding

This study is supported by R01HL122215 (R.S.T, L.S.H), K08HD109636 (K.L.K), March of Dimes Basil O’Connor Award (K.L.K).

Author information

Authors and Affiliations

Authors

Contributions

K.L.K was responsible for the data analysis and interpretation and wrote the initial and final drafts. E.R. was responsible for data collection, data analysis and interpretation, and wrote the initial and final drafts. J.E.S was responsible for the data analysis and interpretation and revised the manuscript. S.E was responsible for data collection and revised the manuscript. D.M.H was responsible for study design and revising the manuscript C.L.R was responsible for data interpretation and revising manuscript. C.T and J.B were responsible for data collection and revising manuscript. D.M.H, L.S.H, and R.S.T were responsible for study design, data analysis and interpretation, and revising manuscript. All authors approved the final version of manuscript.

Corresponding author

Correspondence to Robert S. Tepper.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Consent statement Patient consent was obtained prior to enrollment as described in methods section.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kua, K.L., Rhoads, E., Slaven, J.E. et al. Decreased vascular reactivity associated with increased IL-8 in 6-month-old infants of mothers with pre-eclampsia. Pediatr Res (2024). https://doi.org/10.1038/s41390-024-03132-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41390-024-03132-4

Search

Quick links